⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
ROSEN, A RANKED AND LEADING FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT
accessnewswire.com
CORT
Pomerantz LLP Issues Reminder to Corcept Therapeutics Incorporated Shareholders – CORT
accessnewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
accessnewswire.com
CORT
Alger Russell Innovation Index Updates for First Quarter 2026
prnewswire.com
CORT
DT
GTLB
PAYC
PCOR
PEGA
PSTG
TTD
ALGN
DOX
ENPH
FFIV
GNTX
MRK
MTCH
OGN
Corcept Therapeutics Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights – CORT
globenewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights – CORT
globenewswire.com
CORT
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
prnewswire.com
CORT
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors
globenewswire.com
CORT
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors
globenewswire.com
CORT
Shareholders who lost money in shares of Corcept Therapeutics (NASDAQ: CORT) should contact Wolf Haldenstein immediately
globenewswire.com
CORT